Applied DNA Sciences Awarded Additional Funding from Stony Brook University
31 July 2006 - 11:45PM
PR Newswire (US)
STONY BROOK, N.Y., July 31 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC:APDN) (BULLETIN BOARD: APDN) , a DNA security
solutions company, today announced that its co-development project
with Stony Brook University has been extended for at least a year
based upon progress generated since the project began in February
2006. The initial grants funded the further development of APDN's
DNA library and the completion of additional prototypes that will
allow APDN to extend its platform to additional industries. APDN
uses DNA encryption to authenticate products and identify
counterfeits. Funding awarded to this project by the University's
Center for Biotechnology ("Center"), a New York State Center for
Advanced Technology, now totals $158,011.54. Dr. Clinton T. Rubin,
Director, Center for Biotechnology and Professor and Chair,
Department of Biomedical Engineering, Stony Brook University,
stated, "We are very pleased to continue to facilitate the
collaboration between the Center and Applied DNA Sciences. This
grant will help continue to provide resources and support to fuel
the growth and commercialization of forensic- based technologies."
Leading this project on behalf of the Center is Dr. Sanford Simon,
Professor of Biochemistry, Cell Biology, and Pathology, Stony Brook
University, and a director of APDN, "The first stage of this
project, which is essentially creating a library of unique
sequences of plant DNA, has been completed." "Thanks to the support
from the Center for Biotechnology for this project, we are able to
extend our uses of the company's unique plant chimers into new
commercial markets that have been heretofore inaccessible for DNA
markings. We are now expanding our reach from consumer products and
art to pharmaceuticals. The first grant has helped APDN to assemble
prototypes of products that we can demonstrate to our clients,"
stated Dr. Benjamin Liang, Strategic Technology Officer for Applied
DNA Sciences. About Applied DNA Sciences, Inc. Applied DNA
Sciences, Inc. (APDN) develops proprietary DNA-embedded security
solutions that use plant DNA to verify authenticity and protect
corporate and government agencies from counterfeiting, fraud,
piracy, product diversion, identity theft and unauthorized
intrusion into physical plant and databases. Our common stock is
registered under Section 12(g) of the Securities Exchange Act of
1934 and is listed on the Over-The-Counter Bulletin Board under the
symbol "APDN". Contact: MeiLin Wan, Applied DNA Sciences, Inc., 25
Health Sciences Drive, Stony Brook, New York 11790; Tel: 631-444-
6370; Fax: 631-444.8848 http://www.adnas.com/. The statements made
by Applied DNA Sciences, Inc. may be forward-looking in nature and
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe the Company's future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA Sciences, Inc. Actual results
could differ materially from those projected due to changes in
interest rates, market competition, changes in the local and
national economies, and various other factors detailed from time to
time in Applied DNA Sciences' SEC reports and filings, including
our Annual Report on Form 10-KSB, filed on January 12, 2006, our
subsequent Quarterly Reports on Form 10-QSB, and our Current
Reports on Form 8-K. The Company undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events. DATASOURCE: Applied DNA
Sciences, Inc. CONTACT: MeiLin Wan of Applied DNA Sciences, Inc.,
631-444-6370, fax: 631-444-8848 Web site: http://www.adnas.com/
Copyright